Related Experiment Video
Updated: Jun 6, 2026
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Using bevacizumab to treat metastatic cancer: UK consensus guidelines
D Miles1, J Bridgewater, P Ellis
1Mount Vernon Cancer Centre, London.
British Journal of Hospital Medicine (London, England : 2005)
|December 8, 2010
Summary
Practical guidelines for bevacizumab use are now available for oncologists. This guidance, developed by expert oncologists and a cardiologist, focuses on managing patients receiving bevacizumab.
Area of Science:
- Oncology
- Cardiology
- Pharmacology
Background:
- Bevacizumab is an important anti-cancer drug, but clear usage guidelines for oncologists are scarce.
- Managing side effects, such as hypertension, is crucial for patient safety.
Framework:
- Expert consensus was used to develop practical guidelines.
- Eight experienced oncologists and one cardiologist collaborated on the framework.
Implementation:
- The guidelines focus on the practical management of patients undergoing bevacizumab therapy.
- Available clinical data informed the development of these recommendations.
Implications:
- This guidance aims to improve the safe and effective use of bevacizumab in clinical practice.
- Enhanced management strategies can lead to better patient outcomes and treatment adherence.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...